top of page

Cerebrospinal Fluid (CSF)

A Gold Standard Biosample in Diagnostics and Research

Cerebrospinal fluid (CSF) is made by the choroid plexus in the ventricles of the brain and flows through the ventricles, subarachnoid space, and spinal canal. The composition of CSF is tightly regulated by the blood-brain barrier, which prevents the entry of large molecules and pathogens into the CNS. The normal CSF contains a low number of cells, mainly lymphocytes and monocytes, and a low protein concentration. 

"CSF can be used as a diagnostic and research tool for neurological disorders." 

In clinical practice, CSF analysis is an essential diagnostic tool for various neurological disorders, including infections, inflammatory diseases, and malignancies. The most common CSF tests include cell count, protein and glucose levels, and microbiological cultures. Abnormal results of these tests can help diagnose conditions such as meningitis, encephalitis, multiple sclerosis, and brain tumors.

The unique properties of CSF have made it an important biosample for researchers studying the central nervous system. Some key areas of CSF research include:

Biomarker discovery

Identifying new biomarkers in CSF can lead to better diagnostic tools and a deeper understanding of the pathophysiology of neurological diseases.

Drug delivery

Researchers are developing methods to deliver drugs directly into the CSF, bypassing the blood-brain barrier and potentially improving the efficacy of treatments for neurological disorders.

Brain-gut-microbiome axis

Studies suggest that the composition of CSF may be influenced by the gut microbiome, revealing possible links between gut health and neurological conditions.


Investigating the role of CSF in the repair and regeneration of damaged neural tissue could lead to novel therapeutic strategies for conditions like spinal cord injury and stroke.

As our understanding of the central nervous system and its associated diseases continues to grow, the role of CSF in diagnostics and research will only become more critical. With the ongoing development of new techniques for analyzing and manipulating CSF, the future of neurological medicine promises to be both exciting and transformative. 

When considering a CSF biosamples provider, researchers should check factors such as sample quality, storage conditions, and the availability of associated clinical data and confirm that informed consent is a mandatory requirement from patients before acquiring their biosamples for research purposes. Additionally, researchers must adhere to strict ethical guidelines, follow relevant regulations, and respect patient privacy. 

Please click on the links below to inquire about the Compare Biomarket® range of clinical biospecimens and services suitable for your unique human health research needs.

Compare Biomarket Logo



Latest Biosamples, Services and Research Developments

Human Biospecimens for Acute Myeloid Leukaemia Research

Elucidating Molecular and Genetic Characteristics

Board-Certified Pathology Review

Ensuring FFPE Tissue Specimens are Accurately Characterized

Fresh Viable Tissue

Applications Include Biology, Medicine and Pharmacology

bottom of page